The Effect of the Corneal Epithelium on the Intraocular Penetration of Fluoroquinolone Ophthalmic Solution

Japanese Journal of Ophthalmology

Volumn 48, Issue 2, 2004, Pages 93-96

  Fukuda, Masamichi ^a   Inoue, Amane ^a   Sasaki, Kazuyuki ^a   Takahashi, Nobuo ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Corneal permeability coefficients; Fluoroquinolone ophthalmic solutions; Intraocular penetration; Maximum concentration in the aqueous; Removed rabbit corneal epithelium

Indexed keywords

EYE DROPS; LEVOFLOXACIN; NORFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AQUEOUS HUMOR; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; CORNEA EPITHELIUM; DOSE TIME EFFECT RELATION; DRUG FORMULATION; DRUG PENETRATION; DRUG TISSUE LEVEL; EYE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MAXIMUM ALLOWABLE CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ANIMALS; ANTI-INFECTIVE AGENTS; AQUEOUS HUMOR; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORNEA; EPITHELIUM, CORNEAL; FLUOROQUINOLONES; MALE; NORFLOXACIN; OFLOXACIN; OPHTHALMIC SOLUTIONS; RABBITS;

EID: 1842607593     PISSN: 00215155     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10384-003-0033-z     Document Type: Article

References (15)

1. Sasaki K, Mitsui Y, Fukuda M, Oishi M, Ohashi Y. Measurement of AQCmax as a pharmacokinetic parameter for antimicrobial ophthalmic solutions. Atarashii Ganka (J Eye) 1995;12:787-790.
2. Mitsui Y, Oishi M, Sasaki K, Ohashi Y. Proposal of AQCmax as a pharmacokinetic parameter for ophthalmic solutions. Atarashii Ganka (J Eye) 1995;12:783-786.
3. Fukuda M, Sasaki K. General purpose antimicrobial ophthalmic solutions evaluated using a new pharmacokinetic parameter of maximum drug concentration in aqueous. Jpn J Ophthalmol 2002;46:384-390.
4. Fukuda M, Sasaki K. Intraocular drug distribution to tissues after treatment with ofloxacin ophthalmic solution. Nihon Ganka Kiyo (Folia Ophthalmol Jpn) 1986;37:823-828.
5. Oishi M, Omomo A, Sakagami F, Tazawa H, Kusajima H, Uchida H. Study on retention time in cul-de-sacs and intraocular dynamics of norfloxacin ophthalmic solution. Nippon Ganka Gakkai Zasshi (Acta Soc Ophthalmol Jpn) 1987;91:161-167.
6. Sasaki K, Fukuda M, Ohyama T, Tsuzuki H. Dynamics of cefmenoxime ophthalmic solution in ocular tissues and its clinical application. Tokyo: University of Tokyo Press; 1985. p. 1055-1056.
7. Fukuda M, Yoshitake Y, Sasaki K. The uptake of fluoroquinolone agent drugs by cultured human conjunctival SIRC rabbit corneal cells. Nippon Ganka Gakkai Zasshi (J Jpn Ophthalmol Soc) 1999;103:576-579.
8. Fukuda M, Sasaki K. In vitro topically applied fluoroquinolone penetration into the anterior chamber. Nippon Ganka Gakkai Zasshi (J Jpn Ophthalmol Soc) 1995;99:532-536.
9. Schoenwaid RD. Ocular drug delivery-pharmacokinetic considerations. Clin Pharmacokinet 1990;18:255-269.
10. Lee VHL, Robinson JR. Topical ocular drug delivery: recent developments and future challenges. J Ocul Pharmacol 1986;2:66-108.
11. Burstein NL, Anderson JA. Corneal penetration and ocular bioavailability of drugs. J Ocul Pharmacol 1985;1:309-326.
12. Kawahara M, Nakamura M, Fujii S, Kawazu K, Nakata K, Ohashi Y. Comparative studies of corneal epithelial wound healing effects and ocular pharmacokinetics of Cravit and Tarivid ophthalmic solutions after corneal debridement in rabbits. Atarashii Ganka (J Eye) 2002;19:793-796.
13. Fukuda M, Inoue A, Sasaki K. An animal model of corneal bacterial infection induced by intra-corneal injection of Staphylococcus epidermidis. Nippon Ganka Gakkai Zasshi (J Jpn Ophthalmol Soc) 1999;103:506-511.
14. Fukuda M, Hori T, Tomoyuki H, Munekage T, Sasaki K. Intraocular penetration of carbapenem antibacterial agent S-4661 in the rabbit eye. Atarashii Ganka (J Eye) 2002;19:929-933.
15. Sasaki K, Fukuda M, Ohyama T, Tsuzuki H. Dynamics of cefmenoxime ophthalmic solution in ocular tissues and its clinical application. Tokyo: University of Tokyo Press: 1985. p. 1055-1056.